GIBSON CANCER CENTER - srmc.org · Gibson Cancer Center ... To address this problem, and to assist patients in our ... Thanksgiving, the Duke team honored the hard working Gibson

GIBSON CANCER CENTER

2016 Annual Report

Gibson Cancer Center

Page 1

The Gibson Cancer Center is certified by the American College of Surgeons as a Community

Cancer Center. Cancer remains the second leading cause of death in Robeson County (Robeson

County Health Department data ‐ heart disease is the #1 cause of death) with more deaths than the

next 5 causes combined. To address this problem, and to assist patients in our community, we have

a comprehensive Cancer Center able to provide intravenous fluids, chemotherapy, immunotherapy,

blood transfusions, intravenous iron supplementation, access to genetic screening, and external

beam radiation therapy. The medical oncology department, staffed by Duke physicians, also has a

dynamic Hematology Program treating both cancer related and non‐cancer related hematological

problems. The support staff includes nurses, nursing assistants, phlebotomists, dietitian, social

worker, strong/caring clerical and administrative support, and volunteer services including pastoral

care. The Medical Oncology Department with support from Duke University and the SRMC

Institutional Review Board have reviewed and made available to our patients important regional and

national clinical trials. In addition, our patients benefit from excellent primary care and surgical

care.

Based on information from the Center for Disease Control for 2000 ‐2014, the incidence rates

for all cancers in Robeson County is 402.2 cases per 100,000 population. The North Carolina

Cancer Committee Chairman’s 2016-2017 Report


incidence is 457 cases per 100,000 compared to the United States incidence of 443.6 new cancer cases

per 100,000 populations.

At our center, 423 new patients were seen in 2015, including 190 gentlemen and 233 ladies.

Of these, 110 patients (26%) had lung cancer, 104 patients had breast cancer (24.6%) including 1

gentleman. 34 patients (8%) had colon cancer, 24 patients had prostate cancer (5.7%), and 17

patients (4%) had lymphomas. Only 4 patients presented with metastatic breast cancer (Stage IV).

Due to the benefit of screening mammograms, most breast cancers were detected at earlier stages,

Stage I and stage II. Of the patients with lung cancer, 41 (37%) had stage IV disease with metastasis.

Nation‐wide, there is a higher incidence of metastasis (Stage IV) at time of diagnosis of lung cancer.

To address this, in hopes of detecting lung cancers earlier in chronic smokers, SRMC has established

a low‐dose lung cancer screening CT, meeting the national guidelines for screening high risk

smokers or recent former smokers.

Within this year 2017, the Radiation Oncology Department at the Gibson Cancer Center has

initiated stereotactic body therapy, a special and localized radiation treatment with curative

potential for small stage I and II lung lesions in patients not amenable to surgical resection due to

health or other reasons. Previously, the closest available facilities for this treatment option was Cape

Fear Valley Medical Center in Fayetteville, New Hanover Regional Medical Center in Wilmington,

and Duke University Medical Center in Durham.

One of the major preventable risk factors for cancer is smoking tobacco products (followed by

secondhand smoke from family and friends). Nation‐wide, it is estimated that 19% of men, and 13%

of adult women, 22% of Native American Indians were smokers in of 2015. 16‐20% of adult North

Carolinians smoke tobacco products. Further, secondhand smoke is considered a significant risk

factor for lung disease and cancers. The incidence of exposure to secondhand smoke is estimated be

higher in our county than the state average. The Robeson County Health Department, and the


Page 3

Gibson Cancer Center both have active smoking cessation programs for assistance in stopping

smoking. Not only does smoking provide increased risk for developing cancer, but studies have

shown that patients who continue to smoke during and after cancer treatments have a greater risk

for persistent or recurrent cancers and also increased risk for new cancers.

Randomized clinical trials have demonstrated an improvement in quality of life, overall survival, and

cancer specific survival in patients who have a directed dietary and physical fitness program. To

address this important contribution to cancer treatment, a Survivorship Planning and Cancer

Education (SPACE) Program was designed through a coordinated effort by Physical Fitness

Department/SRMC Lifestyle Center/and Dietary. A program meets for 1 hour twice weekly for 12

weeks and includes lectures on cardiovascular health and dietary measures. The number of eager

participants has increased necessitating 2 separate classes per day. A grant was obtained through the

United Way for breast cancer patients and a fund raising event was successful in providing

additional support so that at currently, patients are able to attend free of charge.

Cancer effects not only the individual patient, but also friends, families, and community members. It

affects quality of life for the whole family and community in general. We have a social worker,

financial assistance specialist, assistance from the Department of Social Services, a pastoral

volunteer, and other volunteers to assist in helping the whole person and family as they deal with

cancer and its treatment. There is a large cancer survivorship program which meets monthly at the

Cancer Center for lunch along with interesting crafting projects and pleasant socialization.

We are fortunate that our cancer center has the strong support of the hospital, community, and a

very dedicated, qualified, and caring staff that on a daily basis go beyond the “call of duty”. As

patients and their families deal with cancer or have questions, they are encouraged to contact our


cancer center for additional information (910‐671‐5730). Naturally, information or discussion about a

particular patient is protected by patient privacy/rights.

Thank you for the opportunity to serve our community. We are here if you need us.

I hope that you have enjoyed reviewing this annual report of the Gibson Cancer Center and

our cancer program. A lot of effort went into preparing this report. You will notice in this document

that the program is accredited by the Commission on Cancer (CoC). That is significant because

there are approximately 1500 accredited programs across the nation but these programs treat

approximately 80% of all cancers diagnosed in America. These programs have to meet rigid

standards as set by the CoC. Every three years every program is surveyed by the CoC. Our cancer

program this past fall went through this survey and was accredited for another three years. My role

in this process is to serve as the Cancer Liaison Physician (CLP). I am responsible for providing

leadership and direction to monitor and improve quality within the program. My primary

responsibility is to monitor, interpret, and provide updated reports of our program’s performance

using National Cancer Data Base (NCDB) to evaluate and improve our quality of care. I report to the

Cancer Committee 4 times a year. If the committee finds any area where the quality or

accountability measures falls below the levels of compliance, a quality‐related audit is initiated. I also

share this data with the medical staff and administration. My secondary responsibilities are to report

to our cancer committee the CoC activities, initiatives, and priorities. I also serve as liaison between

Cancer Liaison Physician (CLP)


Page 5

our cancer committee and the American Cancer Society and represent the cancer committee at state

and national meetings. I am proud of being able to work with such dedicated people at Gibson

Cancer Center and this cancer program. This dedication shows both in this annual report and our

recent reaccreditation. You should be assured that you will receive excellent care here if the need

should ever arise.

Hurricane Matthew affected everyone in the Lumberton area as well as everyone who serves

the Lumberton community. In the immediate days after the hurricane, The Duke Cancer Network

team based in Durham, started to solicit donations and sought creative ways to help get supplies to

the Gibson Cancer Center team and their patients. When planes started flying, the Durham team

sent cases of water with the doctors who were going to clinic. When cars could finally get through

from Durham to Lumberton, Duke sent daily loads of items that patients and clinic employees could

not obtain, such as fresh fruit, nutritional supplement drinks, diapers, toiletries, clothes, etc. At

Thanksgiving, the Duke team honored the hard working Gibson staff with “survival bags” to

demonstrate their gratitude for the staff’s tireless dedication and service to their patients. In


December, the Duke Cancer Network, in conjunction with a number of other departments

throughout the Duke University Health System, organized a donation effort to provide toys to more

than 2,000 children displaced by Hurricane Matthew who were living in temporary housing or

hotels. Dr. Linda Sutton, Medical Director of the Duke Cancer Network stated “We are all one big

team and the Duke portion of the team was honored to assist our counterparts at the Gibson Cancer

Center after Hurricane Matthew. Our part was small compared to the amazing efforts of the staff

there. Duke is proud to be associated with the Southeastern Regional Medical Center and the

Lumberton community.”

Photo of Thank You bags for Gibson Staff


Page 7

Campbell Residency Students at Gibson Cancer Center

In 2017 the Duke Cancer Network and Gibson Cancer Center began collaboration with the

Southeastern Health internal medicine residency program allowing internal medicine residents

to rotate at the Gibson Cancer Center. Residents work with a different attending daily and have

opportunities for experiences with our pharmacy, chemotherapy nurses, and radiation oncology

staff. They are introduced to the outpatient world of oncology which is very different compared

to their inpatient experiences. They are exposed to the diagnosis, workup, and treatment of

common cancers (such as breast, colon, and lung) and common hematology issues such as

anemia, venous thrombosis, and MGUS. The residents rotate for 4 weeks as an

elective. Feedback has been good with residents enjoying their rotation and being grateful for

the experience. Also as part of the collaboration, the DCN staff has participated in resident noon

lectures, including giving oncological emergencies talk for the new interns. In the future, we

hope to continue to have more and more residents experience our clinic and be able to

participate in more lectures to give structured education in hematology and oncology

.


Page 1

Internal Medicine Residency Group

Rotating Through Gibson Cancer Center

These residents can also be

seen for a primary care

physician visit at the

Lumberton Residency

Clinic


New Advances in Treatment in Radiation Oncology

We are continually looking for ways to improve patient experience and quality. Two new treatment

initiatives in radiation oncology are focused on improving treatment options with fewer side effects.

These initiatives include respiratory management and stereotactic body radiation therapy (SBRT).

Respiratory Management

Respiratory Management for radiation therapy, also called deep inspiration breath hold, is a special

technique available at Gibson Cancer Center, which may be beneficial to minimize the radiation

exposure to normal heart and lung, particularly for treatment for left sided breast cancer. It can also

be used to minimize movement in the treatment of some cancers where the location may change in

relation to the breathing pattern which will allow for smaller fields and less radiation to normal

tissue. Our #1 goal is to treat all patients safely and effectively. Many factors are explored to

determine if potential benefits for each patient.

For successful respiratory management during radiation therapy, it is important to have a consistent

breathing pattern. Consistency is more important than the amount of air inhaled, or the respiration

rate. Having a consistent breathing pattern helps the therapists in reproducing the same set up daily.

The therapists have equipment that monitors the consistency of the breathing pattern. Anxiety can

lead to erratic breathing patterns, affecting consistency of breathing. This improves with time and

practice.

We do not all breathe the same. When one person takes in a deep breath, their lungs may fill with air

pushing their chest out and their heart down (which is what we are trying to obtain), but another

person may take in a deep breath and fill their lungs low into their

abdomen. When air goes into the abdomen, the heart does not move as much. It may be determined

in planning that the dose to the heart is already so low that there is no further benefit to utilizing

respiratory management technique. The image on the right shows a patient that is breathing

normally and the image on the left with respiratory management. Notice the line diagonal to the

heart. This person would benefit from respiratory management because it moves the heart and more

of the lung out of the planned treatment with less late potential side effects.

In order to determine a patient’s particular anatomy, we need to obtain a respiratory management

CT as well as a normal breathing CT. This is used to determine if respiratory management is

beneficial for each individual patient. The radiation therapy team, comprised of a physician,

radiation therapist, dosimetrist and physicist, determine the best treatment possible.

SBRT

Stereotactic body radiation therapy or SBRT delivers high dose radiation to a small area over a

several days of treatment. It can be used to treat patients with small singular lung cancers with

superior outcomes and greater patient convenience. Based on the positive outcomes SBRT is now

Without Respriatory

Management

With Respriatory Management


Page 1

being used as the model to treat other mobile soft tissue sites including some the liver, pancreas and

prostate cancers.

SBRT patients undergo a 4D planning CT simulation. 4D planning CT’s show movement of the lung,

heart, and tumor in relation to the breathing of the patient. This enables the physician, dosimetrist,

and physicist to see the motion of the tumor and design a plan to maximize the dose to the target

volume while minimizing the dose to healthy surrounding tissue. The patient is placed in an

immobilization device to make the treatment plan reproducible and accurate daily and has a

compression device positioned to minimize changes in the breathing pattern from simulation to

treatment. After the treatment

plan is designed the patient is brought in for treatment. A 4D conebeam CT is acquired and fused

with the 4D CT simulation to ensure accuracy. The physician and the physicist approve the fusion

before treatment is delivered. The patient is on the treatment table for approximately 45 minutes

and has between 3‐5 treatments. This is in comparison to the patient having to come 30‐35 days for a

10 minute treatment.

SBRT is not necessarily the best treatment option for all cancers. The patient must meet specific

criteria in order to be a candidate for this treatment option. At Gibson we began treating patients

that meet these criteria in May of 2017 and have treated 8 patients up to the time of this article. At

the moment we are just treating lung cancers, but hope to expand our program in the near future.


Page 1


2016 Fall Bazaar

In the spring of 2016 a suggestion was made for Gibson Cancer Center to have a Fall Bazaar to help

raise money for the Gibson Caner Center “Navigation Fund”. This fund is used to provide complete

holiday meals for 50‐75 patient’s identified by the social worker. These patient’s identified are usually

on radiation or chemotherapy treatments and have a financial burden due to multiple visits to

providers and the center for required care. The vision for the Gibson Cancer Center Navigation

department and Gibson staff was that this burden will be relieved by providing the patient with a

turkey, ham, or chicken with all the side items to make several dishes to provide a meal for a family

of 4. Meals are provided for Thanksgiving, Christmas, Easter and 4th of July. The Fall Bazaar planning

began with Team Lead Sharon Smith RN. Sharon enlisted multiple assistance from other staff

members, family of staff members and survivors of the “Survivor Dine and Design Team”. Each

person involved created their own craft designs or recipe for fall and Christmas and donated their

item to sell at the Fall Bazaar. These items included: Wreaths, jewelry, painted wine bottles, yule

logs, snowmen designs, homemade soaps, Christmas ornaments, aprons, pillow, bows, cakes, pies,

cookies, jellies and so much more. The Fall Bazaar was presented on November 4th and 5th, 2016 at

Gibson Cancer Center and cancer survivors came out to donate their time to work the Bazaar. The

bazaar was a complete success and Gibson Cancer Center was able to raise over $5000 to benefit

patients and their family members. Due to this success GCC would like to initiate a yearly Fall Bazaar

and plans are now in process for the 2017 Fall Bazaar to take place in October.


Page 1



Page 3


Luncheon honors Gibson family

NEWS, TOP STORIES

By Scott Bigelow - [email protected]

LUMBERTON — A Lumberton man battling cancer thanked the family whose name is on the center where

he is being treated by organizing a luncheon on Thursday in their honor.

“I do have cancer, and the Gibson Center is a wonderful place,” said Jarvis Hodges, who was diagnosed in

2015. “I also want to thank the Gibson family for their part in it. People don’t know all the things Carr Gibson

did for Lumberton and the area.”

The luncheon honored the staff of Southeastern Health’s Gibson Cancer Center and the family of the late M.

Carr and Alice Gibson.


Page 5

Hodges said he wanted to express his appreciation to the Gibson Center and its benefactors.

“From Dr. (Marvarella) Stevenson to the other doctors, nurses and others who have cared for me, this is a

real fine place,” he said. “It’s worth remembering the Gibson’s support.”

Attending the event were Gibsons’ children: Tom and his wife, Jerri; Bek Gibson Merritt; Lilli Anne Gibson;

and Gwen Gibson Eckerson and her husband, Todd.

Carr Gibson, who died in 2009, owned Canal Industries and thousands of acres of timberland, tree farms

and other forestry holdings. He was one of the county’s most influential residents.

Gibson was a “true philanthropist,” said Sissy Grantham, Southeastern Health Foundation executive

director.

“He was an advocate for the people of this area, in particular their health,” Grantham said. “Serving on the

board of directors of Southeastern Health and its Foundation board were true passions for him.”

The Gibson’s started the Ribbons for Cancer Recovery endowment in 1998. In 2002, the 7-year-old center

was renamed the Gibson Cancer Center.

The Gibson Cancer Center serves the region with radiation oncology, medical oncology and blood disorder

treatments. It has had about 18,000 patient visits so far this year.

Tall and soft-spoken, Gibson was a giant in Lumberton. He was elected to the Robeson County Board of

Commissioners and the Lumberton Board of Education. He served eight years on the board of trustees of

what was then Southeastern Regional Medical Center.

Gibson was a trustee of Pembroke State University and a member of the board of directors of Southern

National Corporation. He helped found Lumber River State Park and Lumber River Conservancy, which has

preserved thousands of acres of wetlands and other land along the river.

The Gibson family dined with the staff and had the opportunity to interact with them. The lunch was donated

by Drew Bullard and the Smithfield’s restaurant in Lumberton.


Smith awarded SeHealth’s highest nursing honor

Registered Nurse Sharon Smith, of Gibson Cancer Center’s (GCC)

Patient Navigation department, was named Southeastern Health’s (SeHealth) 2017 Baker Nurse of

Excellence during a ceremony hosted by the organization’s Professional Growth Council on May 9 as

part of National Nurses Week.

Smith initiated GCC’s monthly “Dine and Design” art therapy sessions. She volunteered at health fairs,

church functions and Relay for Life to get the word out to her community about the importance of

cancer screenings, early detection and the solid possibilities of a cure. She was instrumental in helping

set up the Navigation Fund through the Southeastern Health Foundation, which helps fund screenings

and services for patients who are not covered by existing grants.

“Following the June 2015 fire at Gibson Cancer Center, Smith was always one of the first to arrive and

last to leave to ensure there was not a break in the service provided to our patients,” said Patient

Navigator and Physician Assistant Catherine Gaines. “She is a member of our Community Outreach

Committee, SeHealth’s Cancer Committee, our Patient Advisory Council, Southeastern Research

Council and team lead for art therapy. She is a very large cog in the wheel upon which our cancer center

runs.”

Smith and her husband, Rick, live in Lumberton and have one daughter, Megan Williamson. She has

worked for SeHealth for 14 years.

In addition to Smith, three other 2017 finalist nominees were Suzanne Jackson, Deborah Peterson and

Sandra Price. The winner was selected by a panel based on nomination applications submitted by peers


Page 7

as well as interviews. Past Baker winners are Cynthia Kinlaw, 2016; Tammy McDuffie, 2015; and

Elizabeth Moore, 2014.

The Baker Nurse of Excellence award, formerly known as the Nurse of the Year, was renamed in 2014

in honor of Dr. Horace Baker, Sr., founder of the Baker Sanatorium which later merged with Thompson

Hospital to form what was known as the Baker-Thompson Memorial Hospital in Lumberton in 1946.

These two older facilities were replaced by a new 140-bed hospital known as Robeson County Memorial

Hospital in 1953 which later became Southeastern Regional Medical Center. The overall organization

was renamed Southeastern Health in 2013 but the medical center retained the Southeastern Regional

Medical Center name. To learn more about SeHealth, logon to www.southeasternhealth.org.


The first step in confirming diagnosis of cancer is obtain a biopsy

of the radiographically or clinically suspicious lesion to confirm cancer. In accordance with national

guidelines, the positive biopsies of our patients with lung cancer are being tested for several genetic

mutations which may allow the patient to receive an oral therapy in place of intravenous chemotherapy

or receive one of several recently available lung cancer treatments which can modify and "enhance" the

body’s immune system response to cancer. All of the special tests are available at our hospital or in

coordination with national pathology testing centers. It usually takes 5-7 days to get these test results.

One limitation inherent to all hospitals nationwide is the ability to have sufficient tissue sample for

testing. Sometimes, despite excellent medical and technical skills using state-of-the-art equipment,

biopsies of a clearly suspicious lesion can be non-diagnostic (does not show cancer tissue), or there may

be insufficient tissue to permit additional testing. If necessary, patients may require additional biopsies

in order to identify and maximize the potential opportunities available for treatment for lung cancer

patients over the last several years. Special testing for tumors of patients with lung cancer include

epidermal growth factor receptor mutation (EGFR), ROS-1 (special receptor tyrosine kinase), anaplastic

lymphoma kinase (ALK) mutation, and PDL1 (Programmed Death Ligand 1) expression by tumor and

immune cells. You may have seen some of the popular advertisements with medications and treatments

on TV and in magazines. Lung cancer patients having detectable mutations for EGFR, ROS-1, and

ALK may be able to receive treatment for the cancer with oral medication taken daily with excellent

results (in much the same way as you would take the daily blood pressure or diabetic medication), as

opposed to receiving a standard intravenous chemotherapy. Patients whose tumors express PDL1 may

Lung Cancer


Page 9

be able to receive “immune checkpoint inhibition therapy” using one of several FDA approved antibody

preparations which are usually given intravenously every 2-3 weeks depending on the medication

selected. At present, our patients, family, and friends with stage IV lung cancer can be helped but there

is no cure. Hopefully that can change in the future.

There has been excellent progression in available treatment for lung cancers with these medications.

Unfortunately, most patients do not meet the criteria (tumor pathology does not exhibit those

changes/mutations which would indicate a beneficial response to treatment). The response rate for

these medications are similar to what you might expect from a person taking antibiotic therapy.

Different bacterial infections respond to different antibiotic therapies. Not everybody benefits from

the same antibiotic therapy, and sometimes people can respond initially to antibiotic/medication

and then have relapses. In this regard, it is estimated that 10‐20% of patients with lung cancer will

have the mutations in EGFR, ROS‐1, or ALK for which treatment with the oral medication will be

beneficial. Also, like antibiotics, these new cancer therapies can be associated with potential

medication induced side effects. There have also been rare fatalities caused by treatment with these

medications. Importantly, when patients respond to these cancer therapies, there has been

significant improvements in quality of life and in overall survival.

Lung cancer remains a leading cause of cancer death in men and women. The American Cancer

Society estimates there will be 155,870 lung cancer deaths in the United States in 2017. We are

excited by the continued improvements in therapies available to our lung cancer patients and that

we are able to offer these new advancements to our patients and community of the Gibson Cancer

Center. There is a lot of publicity in the news, and magazines regarding these medications. Not

everybody can benefit. Please contact us at the Gibson Cancer Center if you have any questions

regarding these new advances.


Molecular Testing for Lung Cancer

Advanced lung cancer patients with targetable genetic alterations have improved

survival when they are treated with targeted agents rather than traditional systemic

chemotherapy. According to the ACCC, community cancer centers sometimes have more

difficulty ensuring testing for actionable genetic alterations occurs in lung cancer patients

compared to academic centers. In 2015 the Duke Cancer Network surveyed providers at 7

of its clinical and affiliate sites (medical oncology, pathology, proceduralists) and reviewed

path reports of lung cancer patients to evaluate the state of molecular testing at each

site. Barriers to ensuring that all eligible lung cancer patients received appropriate

molecular testing based on ASCO and NCCN guidelines included: lack of education of

providers on molecular testing, molecular testing not being ordered, desire for more

information on testing costs, inadequate tissue specimens for testing, and long turn-around-

time for test results. Use the electronic medical record capabilities to ensure testing is

ordered and results are received by the provider. One way we plan to address these

barriers is to use the EMR to remind the provider to check to see that molecular testing has

been ordered for eligible patients and ensure that those results are reviewed. Currently, we

are testing an intervention at Gibson Cancer Center where an alert is entered by the patient

navigator for new lung cancer patients eligible for molecular testing to indicate that tests

have been ordered and results are pending, tests have not been ordered, or there was not

enough tissue available to perform molecular testing. This alert begins at the time of the

new patient evaluation and is active for the next 8 weeks so every time their chart is

accessed during this time period, the provider is reminded of the status of the patient’s

molecular testing. At the end of 3 months, we will determine if this helped improved testing


Page 11

rates and whether or not providers found it helpful or annoying. Other strategies to address

identified barriers are also being developed, including an educational program.

Gibson Cancer Conference’s

As a major component of our cancer program, multi-disciplinary cancer conferences are held

twice a month. These meetings provide a format for physicians to discuss best treatment practices by

focusing on pre-treatment evaluations, staging and treatment strategies. In addition, cancer conferences

are opportunities for physicians to confer on difficult or unusual cases.

Furthermore, cancer conferences act as an educational forum for participants by providing

technological updates and scientific advancements in the arena of cancer diagnosis and treatment.

Physicians, physician assistants and nurse practitioners receive credit hours in Category I of the

Physician’s Recognition Award of the American Medical Association through the Southern Regional

AHEC for their involvement in tumor boards.

To ensure the multi-disciplinary nature of cancer conferences, various physician specialties are

represented including, but not limited to, medical oncology, radiation oncology, pathology, radiology,

surgery and internal medicine. In addition to the physician component, nursing and ancillary healthcare

professions such as dietary, counseling, clinical trials, pharmacy, palliative care as well as rehab service

professionals also participate in the meetings. These allied healthcare professions provide additional

perception into the care of cancer patients. Even though numerous individuals attend, all participants

adhere to strict confidentiality standards.

Southeastern Health along with Campbell University’s Jerry M. Wallace School of Osteopathic

Medicine has teamed up to train medical students at SeHealth and other affiliates of Southeastern

Health. We are excited that these medical students from Campbell now participate in our cancer


Page 1

conferences. Our cancer conferences are held the first and third Monday of each month with the

exception of holidays. In the event that a cancer conference falls on a holiday, the cancer conference will

be held the following Monday. Our cancer conferences are held in the newly-renovated 8,200-square-

foot space for the medical education program on the 4th floor at Southeastern Health. The space is the

education hub of the organization offering student lockers, a 100-seat classroom, a small classroom, an

electronic medical library, a resident/student lounge and meeting room, as well as administrative offices

for the medical education program.


I graduated from Bladenboro High School. After graduation, I attended Pembroke State University as

well as Robeson Community College. I worked as an agent for Nationwide Insurance Company for 40

years.

My parents pastored a number of small mission churches in my youth. We were very involved

in community and church activities. We were taught to serve others. I taught Sunday School, led

youth groups, worked with seniors plus served on deacon board, directed youth and adult choirs.

When the opportunity to serve as Volunteer Chaplain came at Gibson Cancer Center through

the encouragement of Pastor Brumfield and Chaplain Dean Carter, it was a milestone in my life. It is

a joy to be able to speak with patients, staff, and physicians at Gibson Cancer Center. My day is

fulfilled when I can eak encouragement to anyone who is down. It is so rewarding to talk with

patients who are going through difficult times and encourage them to connect with those who need

encouragement. Other ways I reach out to the patients is by giving them a blanket or pillow,


Page 3

speaking kind words, telling them a motivational story, sharing a scripture and, by all means, having

a prayer. I want to be that person they can look to for all of the encouragement the patient and or

family needs while going through such a life changing event in their life.

I help with Survivors’ Day, Terrific Tuesday, Cancer Support Group or any activity where help

is needed. My goal is to encourage one to seize the opportunity to encourage someone else. I’m

thankful for the support of the whole staff from the Valet parking attendant to the Director in my

effort to ease the trauma of the problem the patients find themselves involved in.


Sex

M F Analy Aliv Exp Stg 0 Stg II Stg III

2 0 2 1 1 0 2 0

1 0 1 1 0 0 1 0

1 0 1 0 1 0 1 0

37 44 75 46 35 1 12 24

3 1 4 3 1 0 1 2

2 2 4 1 3 0 1 0

2 3 5 5 0 0 0 2

15 20 31 26 9 1 6 13

4 6 10 8 2 0 3 3

1 0 1 1 0 0 0 1

2 3 5 4 1 1 2 1

0 3 2 2 1 0 1 0

0 1 1 1 0 0 0 0

5 4 9 8 1 0 0 8

3 3 3 2 4 0 0 0

4 8 12 6 6 0 2 4

0 2 2 1 1 0 1 0

4 6 10 5 5 0 1 4

0 1 1 1 0 0 0 1

6 0 5 1 5 0 0 1

1 2 3 1 2 0 1 0

4 7 10 2 9 0 1 1

73 43 110 29 87 1 6 43

4 1 5 4 1 1 1 3

69 42 105 25 86 0 5 40

0 1 0 0 1 0 0 0

0 1 0 0 1 0 0 0

3 1 3 3 1 0 0 0

2 1 3 2 1 0 0 0

1 0 0 1 0 0 0 0

1 103 97 90 14 17 30 13

1 103 97 90 14 17 30 13Breast 104 (24.4%) 7 25 4

BREAST 104 (24.4%) 7 25 4

Other Non-Epithelial Skin 1 (0.2%) 1 0 0

Melanoma -- Skin 3 (0.7%) 0 1 1

SKIN EXCLUDING BASAL & S4 (0.9%) 1 1 1

Soft Tissue (including Heart) 1 (0.2%) 1 0 0

SOFT TISSUE 1 (0.2%) 1 0 0

Lung & Bronchus 111 (26.1%) 6 15 42

Larynx 5 (1.2%) 0 0 0

RESPIRATORY SYSTEM 116 (27.2%) 6 15 42

Pancreas 11 (2.6%) 1 1 7

Other Biliary 3 (0.7%) 0 0 2

Liver & Intrahepatic Bile Duct 6 (1.4%) 1 0 3

Anus, Anal Canal & Anorectum1 (0.2%) 0 0 0

Rectum 10 0 2 2

Rectosigmoid Junction 2 0 0 1

Rectum & Rectosigmoid 12 (2.8%) 0 2 3

Large Intestine, NOS 6 3 0 2

Sigmoid Colon 9 0 1 0

Descending Colon 1 0 1 0

Transverse Colon 3 1 0 1

Ascending Colon 5 0 0 1

Appendix 1 0 0 0

Cecum 10 0 3 1

Colon Excluding Rectum 35 (8.2%) 4 5 5

Small Intestine 5 (1.2%) 0 0 1

Stomach 4 (0.9%) 0 0 1

Esophagus 4 (0.9%) 0 0 0

DIGESTIVE SYSTEM 81 (19.0%) 6 8 22

Gum & Other Mouth 1 (0.2%) 0 0 0

Salivary Glands 1 (0.2%) 0 0 0

ORAL CAVITY & PHARYNX 2 (0.5%) 0 0 0

Stage Distribution - Analytic Cases

Primary Site Total (%) NA Stg I Stg IV

Class of Stat

Summary by Body System, Sex, Class, Status and Best CS/AJCC Stage ReportFilter(s): Quick Filter: Year:1ST CONTACT YEAR 2015-2015


Page 5

Summary by Body System, Sex, Class, Status and Best CS/AJCC Stage ReportFilter(s): Quick Filter: Year:1ST CONTACT YEAR 2015-2015

Sex

M F Analy Aliv Exp Stg 0 Stg II Stg III

Stage Distribution - Analytic Cases

Primary Site Total (%) NA Stg I Stg IV

Class of Stat

0 14 12 10 4 0 1 3

0 4 3 4 0 0 0 3

0 4 4 2 2 0 0 0

0 5 4 3 2 0 0 0

0 1 1 1 0 0 1 0

26 0 23 20 6 0 13 0

24 0 21 18 6 0 13 0

2 0 2 2 0 0 0 0

10 6 16 14 2 7 1 1

7 3 10 10 0 7 0 0

3 3 6 4 2 0 1 1

3 1 4 1 3 0 0 0

2 1 3 0 3 0 0 0

1 0 1 1 0 0 0 0

5 3 7 7 1 0 1 0

5 2 6 7 0 0 1 0

0 1 1 0 1 0 0 0

12 5 16 12 5 0 4 2

2 1 3 3 0 0 1 2

10 4 13 9 5 0 3 0

5 2 7 3 4 0 3 0

5 2 6 6 1 0 0 0

3 2 5 3 2 0 0 0

3 2 5 3 2 0 0 0

1 0 1 1 0 0 0 0

1 0 1 1 0 0 0 0

1 1 2 1 1 0 0 0

1 1 2 1 1 0 0 0

13 12 17 11 14 0 0 0

13 12 17 11 14 0 0 0

190 236 390 249 177 26 70 86Total 426 36 73 82

Miscellaneous 25 (5.9%) 8 0 0

MISCELLANEOUS 25 (5.9%) 8 0 0

Mesothelioma 2 (0.5%) 0 0 1

MESOTHELIOMA 2 (0.5%) 0 0 1

Lymphocytic Leukemia 1 (0.2%) 0 0 0

LEUKEMIA 1 (0.2%) 0 0 0

Myeloma 5 (1.2%) 0 0 0

MYELOMA 5 (1.2%) 0 0 0

NHL - Extranodal 7 1 5 1

NHL - Nodal 7 0 3 0

Non-Hodgkin Lymphoma 14 (3.3%) 1 8 1

Hodgkin Lymphoma 3 (0.7%) 0 0 0

LYMPHOMA 17 (4.0%) 1 8 1

Other Endocrine including Th1 (0.2%) 0 0 0

Thyroid 7 (1.6%) 1 4 1

ENDOCRINE SYSTEM 8 (1.9%) 1 4 1

Cranial Nerves Other Nervou 1 (0.2%) 0 0 0

Brain 3 (0.7%) 0 0 0

BRAIN & OTHER NERVOUS 4 (0.9%) 0 0 0

Kidney & Renal Pelvis 6 (1.4%) 0 3 1

Urinary Bladder 10 (2.3%) 0 2 0

URINARY SYSTEM 16 (3.8%) 0 5 1

Testis 2 (0.5%) 0 2 0

Prostate 24 (5.6%) 3 4 4

MALE GENITAL SYSTEM 26 (6.1%) 3 6 4

Vulva 1 (0.2%) 0 0 0

Ovary 5 (1.2%) 1 1 3

Corpus & Uterus, NOS 4 (0.9%) 0 0 2

Cervix Uteri 4 (0.9%) 1 0 0

FEMALE GENITAL SYSTEM 14 (3.3%) 2 1 5


NC‐Robeson NC‐BladenNC‐

ColumbusNC‐

CumberlandSC‐Horry AR‐Boone NC‐Scotland

Series1 284 55 45 2 2 1 1

0

50

100

150

200

250

300

2015 County at Diagnosis


Page 7

Documents

GIBSON CANCER CENTER - srmc.org · Gibson Cancer Center ... To address this problem, and to assist patients in our ... Thanksgiving, the Duke team honored the hard working Gibson